Stock MRKR MARKER THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Marker Therapeutics, Inc.

Equities

MRKR

US57055L2060

Delayed Nasdaq
Other stock markets
 09:47:07 2024-05-29 am EDT 		5-day change 1st Jan Change
3.943 USD +0.34% Intraday chart for Marker Therapeutics, Inc. +0.08% -28.31%
May. 15 Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M MT
Apr. 30 Ladenburg Thalmann Starts Marker Therapeutics With Buy Rating, $11 Price Target MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. MRKR Stock
  4. Revisions Marker Therapeutics, Inc.